Examining the Inclusivity of US Trials of COVID-19 Treatment
J Gen Intern Med
.
2021 May;36(5):1443-1445.
doi: 10.1007/s11606-020-06566-8.
Epub 2021 Jan 27.
Authors
Sukarn Chokkara
1
,
Anna Volerman
2
,
Siddhi Ramesh
2
,
Neda Laiteerapong
2
Affiliations
1
University of Chicago, Chicago, IL, USA.
[email protected]
.
2
University of Chicago, Chicago, IL, USA.
PMID:
33506396
PMCID:
PMC7840067
DOI:
10.1007/s11606-020-06566-8
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Drug Treatment*
Coronavirus Infections*
Humans
SARS-CoV-2
Grants and funding
P30 DK092949/DK/NIDDK NIH HHS/United States